Exploratory Study of Genetic Factors Related to the Inhibitory Effect of Tolvaptan on Increased Kidney Volume in Patients with Autosomal Dominant Polycystic Kidney Disease
Not Applicable
- Conditions
- Autosomal Dominant Polycystic Kidney Disease
- Registration Number
- JPRN-UMIN000031976
- Lead Sponsor
- Otsuka Pharmaceutical Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 890
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who did not participate in extension Trial(Refer to ClinicalTrials.gov:NCT01280721 or NCT01214421)
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method